de Jong Monique A M, Corssmit Eleonora P M, Jansen Jeroen C, Potjer Thomas P, Bayley Jean-Pierre L, Hensen Erik F
Department of Otorhinolaryngology and Head and Neck Surgery, Leiden University Medical Center, Leiden, Netherlands.
Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, Netherlands.
Case Rep Otolaryngol. 2024 Mar 20;2024:2111531. doi: 10.1155/2024/2111531. eCollection 2024.
Head and neck paragangliomas are slow growing and highly vascular neuroendocrine tumors. It is currently assumed that variants exclusively cause benign and often multicentric head and neck paragangliomas. Here, we present a patient diagnosed with multiple -linked head and neck paragangliomas who in addition developed paraganglioma metastases to the lung and spine and a primary or metastatic paraganglioma in the head of the pancreas. During the course of the disease, a range of management strategies were deployed for the different head and neck tumors, including total resections, partial resections, and active surveillance. After identification of the paraganglioma metastases, the patient was treated with lanreotide after which the disease remained stable during the 27 months of follow-up.
头颈部副神经节瘤是生长缓慢且血管丰富的神经内分泌肿瘤。目前认为,相关变异仅导致良性且通常为多中心性的头颈部副神经节瘤。在此,我们报告一例被诊断为多发头颈部副神经节瘤的患者,该患者还出现了副神经节瘤转移至肺和脊柱,以及胰腺头部的原发性或转移性副神经节瘤。在疾病过程中,针对不同的头颈部肿瘤采用了一系列管理策略,包括全切除、部分切除和主动监测。在发现副神经节瘤转移后,患者接受了兰瑞肽治疗,之后在27个月的随访期间病情保持稳定。